Both in Biotechnology
Tessera Defense and Homeland Security vs PharmaCyte Biotech
Over the past year HLSQ returned −86.1% and PMCB returned −25.7%; their daily moves had a correlation of -0.01.
HLSQ −86.1% PMCB −25.7%Growth of $1, one year, split-adjusted
| Metric | HLSQ | PMCB |
|---|---|---|
| Price | $0.1770 | $0.3347 |
| Market cap | $3.7M | $3.6M |
| Today | −14.62% | −2.45% |
| 1 month | −59.2% | −20.1% |
| 6 months | — | −55.4% |
| Year to date | — | −53.8% |
| 1 year | — | −66.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $30.5M |
| Dividend yield | — | — |
| Volatility (60d) | — | 61.5% |
| Short % of float | 3.6% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).